{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:50:46Z","timestamp":1791229846064,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,9,1]],"date-time":"2010-09-01T00:00:00Z","timestamp":1283299200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1016\/j.ijrobp.2010.03.010","type":"journal-article","created":{"date-parts":[[2010,6,21]],"date-time":"2010-06-21T01:00:11Z","timestamp":1277082011000},"page":"237-245","source":"Crossref","is-referenced-by-count":88,"title":["Enhancement of Radiation Response in Osteosarcoma and Rhabomyosarcoma Cell Lines by Histone Deacetylase Inhibition"],"prefix":"10.1016","volume":"78","author":[{"given":"Claudia","family":"Blattmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Ehemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Thiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bischof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Witt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig E.","family":"Deubzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Kulozik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Debus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus-J.","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2010.03.010_bib1","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1016\/j.ejca.2009.06.006","article-title":"Long-term outcome after polychemotherapy and intensive local radiotherapy of high-grade osteosarcoma","volume":"11","author":"Hundsdoerfer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib2","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/sj.onc.1210204","article-title":"Discovery and development of SAHA as an anticancer agent","volume":"26","author":"Marks","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1517\/13543784.16.7.1111","article-title":"Vorinostat: A new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma","volume":"16","author":"Duvic","year":"2007","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib4","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1146\/annurev.pharmtox.45.120403.095825","article-title":"Clinical development of histone deacetlyase inhibitors as anticancer agents","volume":"45","author":"Drummond","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1158\/0008-5472.CAN-03-2630","article-title":"Enhanced radiation-induced cell killing and prolongation of \u03b3H2AX foci expression by the histone deacetylase inhibitor MS-275","volume":"64","author":"Camphausen","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib6","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/1078-0432.CCR-04-2088","article-title":"Histone deacetylase inhibitors radiosensitize human melanoma by suppressing DNA repair activity","volume":"11","author":"Munshi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijrobp.2004.12.088","article-title":"Modulation of radiation response by histone deacetylase inhibition","volume":"62","author":"Chinnaiyan","year":"2005","journal-title":"Int J Radiation Oncology Biol Phy"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib8","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/ijc.20774","article-title":"Enhancement of in vitro and in vivo tumor cell radiosensitivity by valproic acid","volume":"114","author":"Camphausen","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0304-3835(98)00383-8","article-title":"Flow cytometric DNA analysis and chromosomal aberrations in malignant glioblastomas","volume":"138","author":"Ehemann","year":"1999","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0304-3835(03)00054-5","article-title":"Flow cytometric detection of spontaneous apoptosis in human breast cancer using the TUNEL-technique","volume":"194","author":"Ehemann","year":"2003","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib11","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/ijc.22401","article-title":"Inhibitors of histone deacetylases as potential therapeutic tools for high-risk embryonal tumors of the nervous system of childhood","volume":"120","author":"Furchert","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib12","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.2005.01.9679","article-title":"Clinical experience with intravenous and oral formulations of the novel histone deacetylase inhibitor suberoylanilide hydroxamic acid in patients with advanced hematologic malignancies","volume":"24","author":"O'Connor","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib13","first-page":"18","article-title":"The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances Gemcitabine-induced cell death in pancreatic cancer","volume":"13","author":"Arnold","year":"2007","journal-title":"Hum Cancer Biol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib14","doi-asserted-by":"crossref","first-page":"10014","DOI":"10.1073\/pnas.180316197","article-title":"Histone deacetylase inhibitor selectively induces p21\/WAF expression and gene-associated histone acetylation","volume":"97","author":"Richon","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib15","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1158\/1078-0432.CCR-06-2672","article-title":"Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma","volume":"13","author":"Mann","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib16","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/jcb.22185","article-title":"Histone deacetylase inhibitors: Potential in cancer therapy","volume":"107","author":"Marks","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib17","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib18","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib19","first-page":"5165","article-title":"Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in","volume":"60","author":"Butler","year":"2000","journal-title":"vivo. Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib20","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.93.12.5705","article-title":"Second generation hybrid polar compounds are potent inducers of transformed cell\u00a0differentiation","volume":"93","author":"Richon","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib21","first-page":"755","article-title":"Vorinostat, a histone deacetylase inhibitor, enhances the response of tumor cell to ionizing radiation through prolongation of \u03b3-H2AX foci","volume":"28","author":"Munshi","year":"2006","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib22","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1097\/CCO.0b013e3283127095","article-title":"Histone deacetylase inhibitors in cancer therapy","volume":"20","author":"Lee","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib23","doi-asserted-by":"crossref","first-page":"58","DOI":"10.2307\/3578171","article-title":"The influence of chromatin structure on the frequency of radiation-induced DNA strand breaks: A study using nuclear and nucleotide monolayers","volume":"126","author":"Ljungmann","year":"1991","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.2307\/3577324","article-title":"Chromatin decondensed by acetylation shows an elevated radiation response","volume":"117","author":"Nackerdien","year":"1989","journal-title":"Radiation Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib25","first-page":"6008","article-title":"Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1","volume":"63","author":"Veuger","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib26","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","article-title":"DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139*","volume":"273","author":"Rogakou","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/S0960-9822(00)00610-2","article-title":"A critical role for histone H2AX in recruitment of repair factors to nuclear foci after DNA damage","volume":"10","author":"Paul","year":"2000","journal-title":"Curr Biol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib28","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1667\/RR3043","article-title":"Dephosphorylation of histone \u03b3-H2AX during repair of DNA-double-strand breaks in mammalian cells and its inhibition by calyculin A","volume":"160","author":"Nazarov","year":"2003","journal-title":"Radiat Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib29","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1128\/MCB.23.16.5706-5715.2003","article-title":"Pathways of DNA double-strand break repair during the mammalian cell cycle","volume":"23","author":"Rothkamm","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib30","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ijrobp.2003.09.028","article-title":"Phosphorylation of histone H2AX as a measure of radiosensitivity","volume":"58","author":"Olive","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/carcin\/23.5.687","article-title":"Sensing and repairing DNA double-strand breaks","volume":"23","author":"Jackson","year":"2002","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib32","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4161\/cbt.8.9.8143","article-title":"Sensitization to gamma-irradiation-induced cell cycle arrest and apoptosis by the histone deacetylase inhibitor trichostatin A in non-small cell\u00a0lung cancer (NSCLC) cells","volume":"8","author":"Zhang","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1006\/bbrc.1996.0911","article-title":"Antisense inhibition of the Rad51 enhances radiosensitivity","volume":"223","author":"Taki","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib34","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1073\/pnas.0408732102","article-title":"Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors","volume":"102","author":"Ungerstedt","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1073\/pnas.0307708100","article-title":"Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promotor-associated proteins, including HDAC1","volume":"101","author":"Gui","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib36","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrd2133","article-title":"Anticancer activities of histone deacetylase inhibitors","volume":"5","author":"Bolden","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib37","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1124\/mol.105.017145","article-title":"The histone deacetylase inhibitor LAQ824 induces human leukemia cell death through a process involving XIAP down-regulation, oxidative injury, and the acid sphingolyelinase-dependent generation of ceramide","volume":"69","author":"Rosato","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bjp.0707608","article-title":"Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells","volume":"153","author":"Condorelli","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib39","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1158\/1078-0432.CCR-06-0914","article-title":"The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances gemcitabine-induced cell death in pancreatic cancer","volume":"13","author":"Arnold","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1080\/09553000050134438","article-title":"The role of G2-block abrogation, DNA double-strand break repair and apoptosis in the radiosensitization of melanoma and squamous cell carcinoma cell lines by pentoxifylline","volume":"76","author":"Theron","year":"2000","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib41","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.21297","article-title":"Involvement of P-glycoprotein and MRP1 in resistance to cyclic tetrapeptide subfamiliy of histone deacetylase inhibitors in the drug-resistant osteosarcoma and Ewing's sarcoma cells","volume":"118","author":"Okada","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2010.03.010_bib42","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ijc.21297","article-title":"Involvement of P-glycoprotein and MRP1 in resistance to cyclic tetrapeptide subfamiliy of histone deacetylase inhibitors in the drug-resistant osteosarcoma and Ewing's sarcoma cells","volume":"118","author":"Okada","year":"2006","journal-title":"Int J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610004141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301610004141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T23:29:07Z","timestamp":1591399747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301610004141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["S0360301610004141"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2010.03.010","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2010,9]]}}}